| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 04/11/2002 | CA2424620A1 Inhalation particles incorporating a combination of two or more active ingredients |
| 04/11/2002 | CA2424567A1 Method to alter sugar moieties |
| 04/11/2002 | CA2424543A1 Component for vaccine |
| 04/11/2002 | CA2424303A1 Amino-substituted tetracyclic compounds useful as anti-inflammatory agents and pharmaceutical compositions comprising same |
| 04/11/2002 | CA2424285A1 Use of lipopeptides or lipoproteins for the treatment of lung infections and lung tumours |
| 04/11/2002 | CA2424279A1 New thiadiazoles and oxadiazoles and their use as phosphodiesterase-7 inhibitors |
| 04/11/2002 | CA2424275A1 Haemophilus influenzae antigens and corresponding dna fragments |
| 04/11/2002 | CA2424222A1 Inhibitors of prenyl-protein transferase |
| 04/11/2002 | CA2423929A1 Carbohydrate-associated proteins |
| 04/11/2002 | CA2423898A1 Ethers of 7-desmethylrapamycin for use in immunosuppression |
| 04/11/2002 | CA2423888A1 Hydroxyesters of 7-desmethylrapamycin |
| 04/11/2002 | CA2423610A1 Split enveloped virus preparation |
| 04/11/2002 | CA2423462A1 Nectin polypeptides, polynucleotides, methods of making and use thereof |
| 04/11/2002 | CA2423436A1 Methods and compositions for modulating t cell activation and uses thereof |
| 04/11/2002 | CA2423307A1 Stabilisation of plasmid inheritance in bacteria |
| 04/11/2002 | CA2421417A1 Pharmaceutically active hydrophilic sulfonamide derivatives as inhibitors of protein junkinases |
| 04/10/2002 | EP1195381A1 Hepatitis c virus epitopes specific for cd4+ t-cell lymphocytes |
| 04/10/2002 | EP1195162A1 Vaccine preparations containing fatty acids as constituent |
| 04/10/2002 | EP1195095A2 Food products with antimicrobial lactic acid bacteria |
| 04/10/2002 | EP1194584A1 Method for producing oligopolysaccharides |
| 04/10/2002 | EP1194581A2 Respiratory syncytial viruses expressing immune modulatory molecules |
| 04/10/2002 | EP1194580A1 In vitro reconstitution of segmented negative-strand rna viruses |
| 04/10/2002 | EP1194576A1 Delivery system |
| 04/10/2002 | EP1194573A2 Arrays of catalytic or pre-catalytic nucleic acids |
| 04/10/2002 | EP1194567A1 Production of complex carbohydrates |
| 04/10/2002 | EP1194563A1 Fimh adhesin-based vaccines |
| 04/10/2002 | EP1194561A2 Donor strand complemented pilin and adhesin broad-based vaccines |
| 04/10/2002 | EP1194560A2 Antigenic neisserial peptides |
| 04/10/2002 | EP1194557A2 An interleukin-1 receptor antagonist and uses thereof |
| 04/10/2002 | EP1194556A1 Methods and compositions for preventing the formation of aberrant rna during transcription of a plasmid sequence |
| 04/10/2002 | EP1194555A1 Methods for making apo-2 ligand using divalent metal ions |
| 04/10/2002 | EP1194550A1 Antimicrobial peptides derived from molluscs |
| 04/10/2002 | EP1194543A2 HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS |
| 04/10/2002 | EP1194525A2 Combination of lactic acid bacteria and its use for the prevention and/or treatment of infections and inflammatory conditions |
| 04/10/2002 | EP1194450A1 Inactivated vaccine against feline calicivirus disease |
| 04/10/2002 | EP1194448A1 Seven transmembrane receptor genes |
| 04/10/2002 | EP1194436A1 Sulfonamidomethyl phosphonate inhibitors of beta-lactamase |
| 04/10/2002 | EP1194427A1 Thiophene-ethyl thiourea compounds and use in the treatment of hiv |
| 04/10/2002 | EP1194416A1 Halopyrimidines |
| 04/10/2002 | EP1194411A1 Benzoylpyridazines |
| 04/10/2002 | EP1194409A1 Pyrazolidinol compounds |
| 04/10/2002 | EP1194406A1 Phenetyl-thiourea compounds for treating hiv infections |
| 04/10/2002 | EP1194404A1 Inhibitors of aspartyl protease |
| 04/10/2002 | EP1194187A1 Antibody-based treatment for streptococcus pneumoniae infection |
| 04/10/2002 | EP1194168A2 Methods and products for manipulating uncoupling protein expression |
| 04/10/2002 | EP1194167A1 Immunotherapy of autoimmune disorders using antibodies which target b-cells |
| 04/10/2002 | EP1194165A1 Tagged epitope protein transposable element |
| 04/10/2002 | EP1194164A1 Prion protein peptides and uses thereof |
| 04/10/2002 | EP1194163A1 Novel methods and medicament for treating infectious diseases involving microbial biofilms |
| 04/10/2002 | EP1194156A1 Method of treating malignancies and viral infections and improving immune function with a dietary supplement |
| 04/10/2002 | EP1194154A1 Use of propionic bacteria for producing propionic acid and/or propionates in the colon |
| 04/10/2002 | EP1194151A1 Integrin receptor antagonists |
| 04/10/2002 | EP1194149A1 Cyclohexenyl-ethyl-thiourea compounds and use |
| 04/10/2002 | EP1194144A1 Antibacterial compounds |
| 04/10/2002 | EP1194143A2 Il-8 receptor antagonists |
| 04/10/2002 | EP1194141A1 Antiviral therapy |
| 04/10/2002 | EP1194137A2 Naphthoquinone derivatives and their use in the treatment and control of tuberculosis |
| 04/10/2002 | EP1194135A2 Methods of treating fungal infections with inhibitors of nad synthetase enzyme |
| 04/10/2002 | EP1178116A9 Sid nucleic acids and polypeptides selected from a pathogenic strain of hepatitis C virus and applications thereof |
| 04/10/2002 | EP1042323B1 Novel camptothecin tetracyclic analogues, preparation, methods, applications as medicines and pharmaceutical compositions containing them |
| 04/10/2002 | EP0950046B1 3,4-disubstituted azetidin-2-one derivatives useful as cysteine proteinase regulators |
| 04/10/2002 | EP0948478B1 ARYL OR HETEROARYL SUBSTITUTED 3,4-DIHYDROANTHRACENE AND ARYL OR HETEROARYL SUBSTITUTED BENZO[1,2-g]-CHROM-3-ENE, BENZO[1,2-g]-THIOCHROM-3-ENE AND BENZO[1,2-g]-1,2-DIHYDROQUINOLINE DERIVATIVES HAVING RETINOID ANTAGONIST OR RETINOID INVERSE AGONIST TYPE BIOLOGICAL ACTIVITY |
| 04/10/2002 | EP0935458B1 Compositions containing at least one nucleic acid |
| 04/10/2002 | EP0930885B1 The use of heparin or heparan sulphate in combination with chitosan for the prevention or treatment of infections caused by herpes virus |
| 04/10/2002 | EP0805815B1 Use of bismuth compounds for the manufacture of medicaments for the treatment of gastric disorders caused by Helicobacter pylori |
| 04/10/2002 | EP0771191B1 Immunological activity of rhamnolipids |
| 04/10/2002 | EP0734387B1 Hiv protease inhibitors |
| 04/10/2002 | EP0694070B1 Recombinant alphavirus vectors |
| 04/10/2002 | EP0607206B1 Composition for inserting nucleic acid complexes into higher eucaryotic cells |
| 04/10/2002 | CN2484951Y Compound plaster for appendicitis |
| 04/10/2002 | CN1344326A Petroviral vectors comprising functional and non-functional splice donor and splce acceptor sites |
| 04/10/2002 | CN1344322A BASBO55 polynucleotide and polypeptide from neisseria meningitidis uses thereof |
| 04/10/2002 | CN1344270A Functionalized heterocycles as chemokine receptor modulators |
| 04/10/2002 | CN1344266A Novel compounds |
| 04/10/2002 | CN1344166A Use of enterobacterium protein ompA associated with antigen for generating antiviral, antiparasitic or antitumoral cytotoxic response |
| 04/10/2002 | CN1344160A Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 04/10/2002 | CN1344155A Transnasal transport/immunisation with highly adaptable carriers |
| 04/10/2002 | CN1343728A Natural plant polyose |
| 04/10/2002 | CN1343673A Thiophosphamino acid ester compound containing 3'-azido-deoxythymidine and its preparing process |
| 04/10/2002 | CN1343672A 3'-azido-deoxythymidine-5'-thiopyhosphamino acid ester compound and its preparing process |
| 04/10/2002 | CN1343500A External-applied broad-spectrum detoxicating medicine for relieving inflammation |
| 04/10/2002 | CN1082508C antivirally active heterocyclic azahexane derivatives |
| 04/10/2002 | CN1082377C Process for extracting from active parts of suffrutescent securinega and its use for preventing and treating AIDS |
| 04/10/2002 | CN1082337C Feeds compsn and nutritious agent contg. triterpenic saponin extract |
| 04/09/2002 | US6369289 Method and manufacture of a wound dressing for covering an open wound |
| 04/09/2002 | US6369241 Multistage reaction of ketoester with 1,3,5-trihydroxybenzene to produce dihydroxyoxocoumarone, coupling and cyclization |
| 04/09/2002 | US6369235 Inhibitors of hiv reverse transcription for treatment of aids |
| 04/09/2002 | US6369226 Substituted benzamide inhibitors of rhinovirus 3C protease |
| 04/09/2002 | US6369222 mGluR antagonists and a method for their synthesis |
| 04/09/2002 | US6369219 Preparation of clavulanate salts |
| 04/09/2002 | US6369210 22012, human carboxypeptidase |
| 04/09/2002 | US6369208 Influenza endonuclease apatamer that inhibits influenza endonuclease and is resistant to cleavage by said enzyme |
| 04/09/2002 | US6369084 Prostaglandin mediated diseases |
| 04/09/2002 | US6369082 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
| 04/09/2002 | US6369066 Substituted 1,3-oxathiolanes with antiviral properties |
| 04/09/2002 | US6369049 Treatment of mastitis |
| 04/09/2002 | US6369038 Closed antisense and sense oligonucleotides and their applications |
| 04/09/2002 | US6369035 3,6-hemiketals from the class of 9A-azalides |
| 04/09/2002 | US6368863 Reagents and methods for modulating gene expression through RNA mimicry |
| 04/09/2002 | US6368635 Gastrointestinal mucosa-adherent matrixes pharmaceutical preparations and a coating composition |